Target intelligence / Profile preview

Potassium voltage-gated channel modifier subfamily V member 1 (KCNV1)

Target
KCNV1
Molecular classification
Ion channel, Voltage-gated potassium channel subunit, Channel modifier (does not form functional channels alone)
01

Overview

Potassium voltage-gated channel modifier subfamily V member 1 (KCNV1, Kv8.1) is a neuronal subunit of the voltage-gated potassium channel family. Unlike typical channel-forming alpha subunits, Kv8.1 does not form functional ion channels on its own, but instead modifies the function of other potassium channel subunits—predominantly those of the Kv2 type—by altering their gating properties and channel kinetics. KCNV1 is expressed primarily in the brain (cerebral cortex, hippocampus, and cerebellum) and is implicated in the regulation of neuronal excitability, with particular significance for neuronal survival under stress conditions. Its (down)regulation is associated with increased vulnerability to neurodegeneration, as observed in models of amyotrophic lateral sclerosis, and genetic variation in KCNV1 is a candidate for epilepsy susceptibility.

Other names
Kv8.1HNKAKCNB3KV2.3Neuronal potassium channel alpha subunit HNKAVoltage-gated potassium channel subunit Kv8.1potassium channel Kv8.1
02

Mechanism of action

Modulation of Kv2 channels (alters inactivation, gating, and density of Kv2.1/Kv2.2 channels); Suppression/abolition of Kv2.1, Kv2.2, and Kv3.4 channel activity at high expression levels

03

Biological functions

Modulation of potassium channel activityRegulation of neuronal excitabilityRegulation of potassium ion flow (as a modifier subunit)Regulation of cell signaling pathwaysCell death and vulnerability in neurons
04

Disease associations

Neurodegenerative disease (e.g., implicated in amyotrophic lateral sclerosis vulnerability)Epilepsy (benign adult familial myoclonic epilepsy susceptibility region)Other neurological disorders (Gand syndrome, Clark-Baraitser syndrome)
05

Safety considerations

Modulation of channel activity could impact neuronal excitability and survivalLoss or dysregulation may increase risk for neurodegenerative disease
06

Biomarkers

Downregulation associated with increased vulnerability in motor neurons (potential biomarker in amyotrophic lateral sclerosis research)

Beyond the preview

Go deeper on Potassium voltage-gated channel modifier subfamily V member 1 (KCNV1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium voltage-gated channel modifier subfamily V member 1 (KCNV1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call